Type to search

Novavax Files for Authorization of its COVID-19 Vaccine in the United Kingdom | Pharmtech Focus
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases | Pharmtech Focus
Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial | Pharmtech Focus